Pharmaceuticals Portfolio Pharmaceuticals Fund Probability of Future Mutual Fund Price Finishing Under 21.03
| FPHAX Fund | USD 26.36 0.20 0.75% |
Pharmaceuticals |
Pharmaceuticals Portfolio Target Price Odds to finish below 21.03
The tendency of Pharmaceuticals Mutual Fund price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 21.03 or more in 90 days |
| 26.36 | 90 days | 21.03 | near 1 |
Based on a normal probability distribution, the odds of Pharmaceuticals Portfolio to drop to $ 21.03 or more in 90 days from now is near 1 (This Pharmaceuticals Portfolio Pharmaceuticals probability density function shows the probability of Pharmaceuticals Mutual Fund to fall within a particular range of prices over 90 days) . Probability of Pharmaceuticals Portfolio price to stay between $ 21.03 and its current price of $26.36 at the end of the 90-day period is about 53.77 .
Assuming the 90 days horizon Pharmaceuticals Portfolio has a beta of 0.96. This usually indicates Pharmaceuticals Portfolio Pharmaceuticals market returns are sensitive to returns on the market. As the market goes up or down, Pharmaceuticals Portfolio is expected to follow. Additionally Pharmaceuticals Portfolio Pharmaceuticals has an alpha of 0.0496, implying that it can generate a 0.0496 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Pharmaceuticals Portfolio Price Density |
| Price |
Predictive Modules for Pharmaceuticals Portfolio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharmaceuticals Portfolio. Regardless of method or technology, however, to accurately forecast the mutual fund market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the mutual fund market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharmaceuticals Portfolio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pharmaceuticals Portfolio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pharmaceuticals Portfolio is not an exception. The market had few large corrections towards the Pharmaceuticals Portfolio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pharmaceuticals Portfolio Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pharmaceuticals Portfolio within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 0.05 | |
β | Beta against NYSE Composite | 0.96 | |
σ | Overall volatility | 1.26 | |
Ir | Information ratio | 0.05 |
Pharmaceuticals Portfolio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharmaceuticals Portfolio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharmaceuticals Portfolio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The fund retains 97.26% of its assets under management (AUM) in equities |
Pharmaceuticals Portfolio Technical Analysis
Pharmaceuticals Portfolio's future price can be derived by breaking down and analyzing its technical indicators over time. Pharmaceuticals Mutual Fund technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pharmaceuticals Portfolio Pharmaceuticals. In general, you should focus on analyzing Pharmaceuticals Mutual Fund price patterns and their correlations with different microeconomic environments and drivers.
Pharmaceuticals Portfolio Predictive Forecast Models
Pharmaceuticals Portfolio's time-series forecasting models is one of many Pharmaceuticals Portfolio's mutual fund analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pharmaceuticals Portfolio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the mutual fund market movement and maximize returns from investment trading.
Things to note about Pharmaceuticals Portfolio
Checking the ongoing alerts about Pharmaceuticals Portfolio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pharmaceuticals Portfolio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| The fund retains 97.26% of its assets under management (AUM) in equities |
Check out Pharmaceuticals Portfolio Backtesting, Portfolio Optimization, Pharmaceuticals Portfolio Correlation, Pharmaceuticals Portfolio Hype Analysis, Pharmaceuticals Portfolio Volatility, Pharmaceuticals Portfolio History as well as Pharmaceuticals Portfolio Performance. Note that the Pharmaceuticals Portfolio information on this page should be used as a complementary analysis to other Pharmaceuticals Portfolio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.